Back
Day Range
$9.31
$9.81
52-Week Range
$9.23
$28.44
Volume
2,514,216
50D / 200D Avg
$13.28
/
$19.16
Prev Close
$9.57
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.9 | 0.3 |
| P/B | 0.5 | 2.9 |
| ROE % | -39.3 | 3.7 |
| Net Margin % | -33.5 | 3.8 |
| Rev Growth 5Y % | 0.7 | 10.0 |
| D/E | 1.4 | 0.2 |
Analyst Price Target
Hold
$21.50
+123.0%
Low: $20.00
High: $23.00
Forward P/E
4.2
Forward EPS
$2.28
EPS Growth (est.)
+0.0%
Est. Revenue
4.1 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.92
$2.90 – $2.95
|
4.3 B | 1 |
| FY2029 |
$2.82
$2.80 – $2.85
|
4.2 B | 1 |
| FY2028 |
$2.67
$2.64 – $2.69
|
4.2 B | 1 |
Key Takeaways
Revenue grew 0.68% annually over 5 years — modest growth
Generating 145.10M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.43%
Capital efficient — spends only 2.20% of revenue on capex
ROIC of 3.73% — low return on invested capital
Growth
Revenue Growth (5Y)
0.68%
Revenue (1Y)-2.75%
Earnings (1Y)N/A
FCF Growth (3Y)-30.89%
Quality
Return on Equity
-39.29%
ROIC3.73%
Net Margin-33.51%
Op. Margin8.07%
Safety
Debt / Equity
1.35
Current Ratio2.76
Interest Coverage2.11
Valuation
P/E Ratio
-0.93
P/B Ratio0.45
EV/EBITDA13.88
Dividend Yield0.08%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.75% | Revenue Growth (3Y) | -4.42% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 0.68% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.25B | Net Income (TTM) | -1.43B |
| ROE | -39.29% | ROA | -16.70% |
| Gross Margin | 35.14% | Operating Margin | 8.07% |
| Net Margin | -33.51% | Free Cash Flow (TTM) | 145.10M |
| ROIC | 3.73% | FCF Growth (3Y) | -30.89% |
| Safety | |||
| Debt / Equity | 1.35 | Current Ratio | 2.76 |
| Interest Coverage | 2.11 | Dividend Yield | 0.08% |
| Valuation | |||
| P/E Ratio | -0.93 | P/B Ratio | 0.45 |
| P/S Ratio | 0.31 | PEG Ratio | 0.00 |
| EV/EBITDA | 13.88 | Dividend Yield | 0.08% |
| Market Cap | 1.33B | Enterprise Value | 4.76B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.25B | 4.37B | 4.66B | 4.45B | 4.14B |
| Net Income | -1.43B | -171.80M | -12.70M | -140.60M | -68.90M |
| EPS (Diluted) | -10.29 | -1.25 | -0.09 | -0.97 | -0.98 |
| Gross Profit | 1.49B | 1.54B | 1.68B | 1.46B | 1.42B |
| Operating Income | 343.30M | 112.90M | 151.90M | 78.90M | 410.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8.54B | 9.65B | 10.81B | 11.02B | 10.43B |
| Total Liabilities | 5.60B | 5.33B | 6.04B | 6.18B | 5.27B |
| Shareholders' Equity | 2.94B | 4.32B | 4.77B | 4.84B | 5.15B |
| Total Debt | 3.97B | 3.62B | 4.07B | 4.32B | 3.69B |
| Cash & Equivalents | 531.60M | 558.80M | 751.30M | 600.70M | 1.86B |
| Current Assets | 2.80B | 2.48B | 2.83B | 2.72B | 3.86B |
| Current Liabilities | 1.01B | 1.04B | 1.59B | 1.11B | 1.59B |